Oppenheimer Asset Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-7,622
| Closed | -$1.14M | – | 1155 |
|
|
2024
Q3 | $1.14M | Buy |
7,622
+695
| +10% | +$104K | 0.01% | 699 |
|
|
2024
Q2 | $945K | Buy |
6,927
+2,048
| +42% | +$279K | 0.01% | 721 |
|
|
2024
Q1 | $738K | Sell |
4,879
-128
| -3% | -$19.4K | 0.01% | 753 |
|
|
2023
Q4 | $631K | Sell |
5,007
-277
| -5% | -$34.9K | 0.01% | 813 |
|
|
2023
Q3 | $495K | Sell |
5,284
-286
| -5% | -$26.8K | 0.01% | 849 |
|
|
2023
Q2 | $497K | Sell |
5,570
-217
| -4% | -$19.4K | 0.01% | 864 |
|
|
2023
Q1 | $620K | Sell |
5,787
-103
| -2% | -$11K | 0.01% | 794 |
|
|
2022
Q4 | $719K | Sell |
5,890
-1,586
| -21% | -$194K | 0.01% | 759 |
|
|
2022
Q3 | $772K | Sell |
7,476
-281
| -4% | -$29K | 0.01% | 734 |
|
|
2022
Q2 | $721K | Sell |
7,757
-3,602
| -32% | -$335K | 0.01% | 770 |
|
|
2022
Q1 | $1.33M | Sell |
11,359
-715
| -6% | -$83.9K | 0.02% | 659 |
|
|
2021
Q4 | $1.62M | Sell |
12,074
-1,121
| -8% | -$151K | 0.02% | 618 |
|
|
2021
Q3 | $2.1M | Buy |
13,195
+2,918
| +28% | +$465K | 0.03% | 521 |
|
|
2021
Q2 | $1.35M | Buy |
10,277
+2,454
| +31% | +$323K | 0.02% | 660 |
|
|
2021
Q1 | $1.01M | Buy |
7,823
+3,339
| +74% | +$430K | 0.02% | 718 |
|
|
2020
Q4 | $748K | Buy |
4,484
+2,133
| +91% | +$356K | 0.01% | 777 |
|
|
2020
Q3 | $363K | Buy |
2,351
+996
| +74% | +$154K | 0.01% | 883 |
|
|
2020
Q2 | $200K | Buy |
1,355
+918
| +210% | +$135K | ﹤0.01% | 1015 |
|
|
2020
Q1 | $49K | Buy |
+437
| New | +$49K | ﹤0.01% | 1265 |
|